Literature DB >> 18179389

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.

Elin Kindberg1, Aukse Mickiene, Cecilia Ax, Britt Akerlind, Sirkka Vene, Lars Lindquist, Ake Lundkvist, Lennart Svensson.   

Abstract

Tickborne encephalitis (TBE) virus infections can be asymptomatic or cause moderate to severe injuries of the central nervous system. Why some individuals develop severe disease is unknown, but a role for host genetic factors has been suggested. To investigate whether chemokine receptor CCR5 is associated with TBE, CCR5Delta32 genotyping was performed among Lithuanian patients with TBE (n=129) or with aseptic meningoencephalitis (n=76) as well as among control subjects (n=134). We found individuals homozygous for CCR5Delta32 (P= .026) only among patients with TBE and a higher allele prevalence among patients with TBE compared with the other groups studied. CCR5Delta32 allele prevalence also increased with the clinical severity of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179389     DOI: 10.1086/524709

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  68 in total

Review 1.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 2.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

3.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

4.  Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development.

Authors:  Rafael E Marques; Rodrigo Guabiraba; Juliana L Del Sarto; Rebeca F Rocha; Ana Luiza Queiroz; Daniel Cisalpino; Pedro E Marques; Carolina C Pacca; Caio T Fagundes; Gustavo B Menezes; Maurício L Nogueira; Danielle G Souza; Mauro M Teixeira
Journal:  Immunology       Date:  2015-06-01       Impact factor: 7.397

5.  Targeting the chemokine receptor CCR5: good for HIV, what about other viruses?

Authors:  Yoav Keynan; Jennifer Juno; Ken Kasper; Ethan Rubinstein; Keith R Fowke
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

6.  Double-edged genetic swords and immunity: lesson from CCR5 and beyond.

Authors:  Sunil K Ahuja; Weijing He
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

Review 7.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

8.  A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Authors:  Xiaoran Tang; Hongliang Jin; Yue Chen; Li Li; Yuanmei Zhu; Huihui Chong; Yuxian He
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 9.  The African diaspora: history, adaptation and health.

Authors:  Charles N Rotimi; Fasil Tekola-Ayele; Jennifer L Baker; Daniel Shriner
Journal:  Curr Opin Genet Dev       Date:  2016-09-16       Impact factor: 5.578

10.  Exome-wide search and functional annotation of genes associated in patients with severe tick-borne encephalitis in a Russian population.

Authors:  Elena V Ignatieva; Andrey A Yurchenko; Mikhail I Voevoda; Nikolay S Yudin
Journal:  BMC Med Genomics       Date:  2019-05-24       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.